Lores Enrique's Form 4 filing
HP Inc (HPQ) · filed Dec 10, 2024
- Accession no.
- 0000950170-24-135132
- Filed
- Dec 10, 2024
- Trade date
- Dec 7-9, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 4 derivative transactions. Open-market sales total $5.00M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lores EnriqueCIK 0001656242 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 7, 2024 | Common Stock | MOption exerciseAcquired | +169,612 | $0.00 | $0 | 200,958 | Direct | |
| Dec 7, 2024 | Common Stock | FTax withholdingDisposed | −80,343 | $36.20 | −$2,908,416.6 | 120,615 | Direct | |
| Dec 9, 2024 | Common Stock | MOption exerciseAcquired | +105,751 | $28.48 | +$3,011,788.48 | 226,366 | Direct | |
| Dec 9, 2024 | Common Stock | SSaleDisposed | −137,094 | $36.45F3 | −$4,997,076.3 | 89,272 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 7, 2024 | Common Stock | MOption exerciseDisposed | −44,345 | –F6 | – | 0 | Direct | |
| Dec 7, 2024 | Common Stock | MOption exerciseDisposed | −64,333 | –F7 | – | 60,042 | Direct | |
| Dec 7, 2024 | Common Stock | MOption exerciseDisposed | −60,934 | –F8 | – | 118,891 | Direct | |
| Dec 9, 2024 | Common Stock | MOption exerciseDisposed | −105,751 | $0.00 | $0 | 317,251 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.145-$36.755, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
As previously reported, on 12/7/2021, the reporting person was granted 120,676 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 4,119 vested dividend equivalent rights.
Referenced by the price of 1 transaction in Table II.
- F7
As previously reported, on 12/8/2022, the reporting person was granted 180,126 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 4,291 vested dividend equivalent rights.
Referenced by the price of 1 transaction in Table II.
- F8
As previously reported, on 12/19/2023, the reporting person was granted 178,336 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,489 vested dividend equivalent rights.
Referenced by the price of 1 transaction in Table II.